Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers [Phase 1, Phase 2]
Phase 1/2 trial update for PEN-221 in somatostatin receptor 2 expressing advanced cancers, including neuroendocrine tumors and small cell lu…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm [Phase 2]
Phase 2 trial evaluating chidamide plus sintilimab in chemotherapy-refractory advanced high-grade neuroendocrine neoplasm; status not yet de…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma [Phase 2]
Phase 2 trial evaluating chidamide with etoposide and cisplatin/carboplatin as first-line therapy for extrapulmonary neuroendocrine carcinom…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study [Phase 2]
A Phase II investigator-initiated trial evaluating safety and tolerability of everolimus as second-line therapy in poorly differentiated neu…
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas [Phase 2]
A Phase 2 clinical trial evaluating temozolomide as second-line treatment for neuroendocrine carcinomas has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery [Phase 2]
Phase 2 trial evaluating mutation-targeted therapy with sunitinib or everolimus in advanced low- or intermediate-grade neuroendocrine tumors…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Avelumab in G3 NEC [Phase 1, Phase 2]
Clinical trial update on avelumab in neuroendocrine carcinoma across Phase 1 and Phase 2 stages. The study is completed.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 trial investigating pembrolizumab for recurrent high-grade neuroendocrine carcinoma (neuroendocrine tumors) has been terminated with…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic （GEP） Neuroendocrine Carcinoma （NEC, WHO Grade 3） as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes [Phase 2]
Phase II study of avelumab as second-line treatment for metastatic gastroenteropancreatic neuroendocrine carcinoma (WHO Grade 3) afteretopos…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3) [Phase 2]
Phase 2 trial investigating everolimus with temozolomide in advanced gastroenteropancreatic neuroendocrine carcinoma (G3) has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients [Phase 2]
Phase II study assessing the efficacy and safety of TLC388 in patients with neuroendocrine carcinomas has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating cisplatin and etoposide with or without veliparib in extensive-stage small cell lung cancer has completed recru…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the effectiveness of SOX as second-line chemotherapy in neuroendocrine carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer [Phase 2]
Results from a Phase 2 trial evaluating 68Ga-DOTATATE PET imaging in neuroendocrine carcinoma have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers [Phase 2]
Phase 2 trial evaluating the combination of bevacizumab, pertuzumab, and octreotide (Sandostatin) for neuroendocrine carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome [Phase 2]
A Phase 2 trial of above-label octreotide LAR for insufficiently controlled carcinoid syndrome in neuroendocrine carcinoma was terminated, w…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: TheraSphere for the Treatment of Liver Metastases [Phase 2]
Phase 2 clinical trial update for TheraSphere in treating liver metastases has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors [Phase 2]
A Phase 2 trial of irinotecan in patients with advanced neuroendocrine tumors, including carcinoma of unknown primary and neuroendocrine car…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) with everolimus in advanced low or intermediate grade neuroendocrine carcinoma; results poste…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases [Phase 2]
Phase 2 clinical trial evaluated isolated hepatic perfusion with melphalan for patients with primary unresectable liver cancer or liver meta…
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma [Phase 2]
An extension study evaluating the safety and efficacy of Atiprimod for neuroendocrine carcinoma has completed its Phase 2 trial.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 update reporting safety and efficacy of Atiprimod in patients with low to intermediate-grade neuroendocrine carcinoma.